NTRK1
Showing 1 - 25 of 86
Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
Recruiting
- Thyroid Cancer
- NTRK fusion assessment
-
Roma, ItalyRegina Elena National Cancer Institute
Mar 31, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)
Not yet recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Providence, Rhode IslandRhode Island Hospital, Brown University
Mar 2, 2023
NTRK Family Gene Mutation Trial in Germany
Recruiting
- NTRK Family Gene Mutation
-
Berlin, Germany
- +22 more
Jan 18, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)
Recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- TPX-0005
- +3 more
-
Canton, OhioGabrail Cancer Research Center
Apr 25, 2023
Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)
Recruiting
- Soft Tissue Sarcoma
- +2 more
- Blood and tumor samples
-
Clermont-Ferrand, France
- +9 more
Dec 8, 2021
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)
Completed
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
-
Orange, California
- +9 more
Jun 7, 2021
Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- +3 more
- Oral repotrectinib (TPX-0005)
-
Los Angeles, California
- +27 more
Aug 9, 2022
Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic NSCLC Trial in Beijing (XZP-5955 tablets)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Locally Advanced or Metastatic Non-small Cell Lung Cancer
- XZP-5955 tablets
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
May 17, 2022
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Selitrectinib (BAY2731954))
Active, not recruiting
- Solid Tumors Harboring NTRK Fusion
- Selitrectinib (BAY2731954)
-
La Jolla, California
- +28 more
Aug 18, 2022
Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life
Recruiting
- Cancer
- +15 more
- Data collection and quality of life questionnaire
-
Graz, Austria
- +40 more
Jul 27, 2021
High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)
Recruiting
- High Grade Glioma
- Diffuse Intrinsic Pontine Glioma
- Larotrectinib
- Larotrectinib surgical
-
Aurora, Colorado
- +17 more
Aug 10, 2022
Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)
Recruiting
- Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
-
Shanghai, ChinaShanghai Chest Hospital
Jan 11, 2021
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))
Recruiting
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Los Angeles, California
- +50 more
Jan 29, 2023
Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))
Completed
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Aurora, Colorado
- +7 more
May 11, 2021
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
- Oral repotrectinib (TPX-0005)
-
Yuma, Arizona
- +175 more
Jan 25, 2023
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))
Recruiting
- Solid Tumors Harboring NTRK Fusion
- BAY2757556 (Larotrectinib, Vitrakvi)
-
Palo Alto, California
- +158 more
Aug 8, 2022
NSCLC, Solid Tumor Trial in Boston (Merestinib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Solid Tumor
-
Boston, Massachusetts
- +1 more
Jan 26, 2022
ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,
Terminated
- ALK Fusion Protein Expression
- +14 more
- Capmatinib
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 14, 2020
Solid Tumors Harboring NTRK Fusion Trial (Selitrectinib (BAY2731954))
No longer available
- Solid Tumors Harboring NTRK Fusion
- Selitrectinib (BAY2731954)
- (no location specified)
Sep 8, 2021
Solid Tumor Trial (TL118 Capsule)
Not yet recruiting
- Solid Tumor
- TL118 Capsule
- (no location specified)
Aug 18, 2023